How an antibiotic acts as an antiviral, hitting the COVID-19 virus with a three-pronged attack
EU to decide on Moderna for kids within 2 months
10 November 2021In Russia, 83% of COVID hospital beds are filled amid surge
10 November 2021How an antibiotic acts as an antiviral, hitting the COVID-19 virus with a three-pronged attack
New research published in the International Journal of Computational Biology and Drug Design describes a novel lipopeptide antibiotic that can inhibit the replication of the SARS-CoV-2 virus, which causes COVID-19. The compound, known as Kannurin, interferes with RNA-dependent-RNA polymerase activation and function, the researchers explain.
